Literature DB >> 9307301

Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation.

M Ostergaard1, H H Rasmussen, H V Nielsen, H Vorum, T F Orntoft, H Wolf, J E Celis.   

Abstract

One hundred fifty fresh bladder tumors were analyzed blindly by two-dimensional PAGE in combination with proteome identification techniques (microsequencing and mass spectrometry) and immunofluorescence of cryostat sections. Of these, six showed protein expression patterns corresponding to squamous cell carcinomas (SCCs). All tumors were already invasive at the time of presentation, and in most cases, the histopathological grade could not be determined with certainty. The more differentiated of the tumors included SCC 589-1, a lesion showing extensive keratinization, and 536-1, a pure SCC that resembled normal skin growing invasively into the muscle. Both tumors expressed keratins 5, 6, 10, 14, 16, 17, and 20, as well as the differentiation-associated proteins psoriasin, psoriasis-associated fatty acid-binding protein (PA-FABP), and galectin 7. SCC 589-1, however, exhibited higher levels of keratin 10, PA-FABP, and galectin 7 and, in addition, expressed keratins 13, 15, and 19, which were not detected in the pure SCC. Involucrin, glutathione S-transferase pi, stratifin (14-3-3 sigma), and the SCC antigen 1, on the other hand, were less abundant in SCC 589-1. In comparison, less-differentiated tumors did not express keratin 10 and were characterized by a decreased expression of keratin 14, psoriasin, PA-FABP, galectin 7, and stratifin (14-3-3 sigma). Indeed, two of these lesions (553-1 and 651-1) could be readily lined up in order of decreasing degree of differentiation based on the expression of these markers. The degree of differentiation of the other two SCCs could not be assessed with certainty because they may represent special cases (SCC 646-1, solid tumor; SCC 485-1, special differentiation pattern). All six SCCs externalized psoriasin to the urine, supporting the contention that this protein, alone or in combination with other polypeptides, may represent a useful marker for the early detection of these lesions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9307301

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

1.  Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFbeta1-dependent regulation of DNA repair.

Authors:  Takashi Kanamoto; Ulf Hellman; Carl-Henrik Heldin; Serhiy Souchelnytskyi
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

Review 2.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

3.  Psoriasin (S100A7) expression and invasive breast cancer.

Authors:  S Al-Haddad; Z Zhang; E Leygue; L Snell; A Huang; Y Niu; T Hiller-Hitchcock; K Hole; L C Murphy; P H Watson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

4.  Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model.

Authors:  Travis Young; Fang Mei; Jinsong Liu; Robert C Bast; Alexander Kurosky; Xiaodong Cheng
Journal:  Oncogene       Date:  2005-09-08       Impact factor: 9.867

5.  14-3-3 sigma positively regulates p53 and suppresses tumor growth.

Authors:  Heng-Yin Yang; Yu-Ye Wen; Chih-Hsin Chen; Guillermina Lozano; Mong-Hong Lee
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

6.  14-3-3 proteins tune non-muscle myosin II assembly.

Authors:  Hoku West-Foyle; Priyanka Kothari; Jonathan Osborne; Douglas N Robinson
Journal:  J Biol Chem       Date:  2018-03-16       Impact factor: 5.157

7.  Undifferentiated pelvic adenocarcinomas: diagnostic potential of protein profiling and multivariate analysis.

Authors:  U J Roblick; F G Bader; C Lenander; U Hellman; K Zimmermann; S Becker; A Ost; A Alaiya; H-P Bruch; R Keller; L Mirow; B Franzén; T Ried; G Auer; J K Habermann
Journal:  Int J Colorectal Dis       Date:  2008-02-22       Impact factor: 2.571

Review 8.  [Squamous cell lesions of the urinary bladder].

Authors:  S Rausch; N Gaisa; R F Youssef; Y Lotan; A Stenzl; T Kälble
Journal:  Urologe A       Date:  2014-03       Impact factor: 0.639

9.  Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.

Authors:  José M A Moreira; Gita Ohlsson; Pavel Gromov; Ronald Simon; Guido Sauter; Julio E Celis; Irina Gromova
Journal:  Mol Cell Proteomics       Date:  2009-09-25       Impact factor: 5.911

10.  Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?

Authors:  Angelika Tölle; Monika Jung; Michael Lein; Manfred Johannsen; Kurt Miller; Holger Moch; Klaus Jung; Glen Kristiansen
Journal:  BMC Cancer       Date:  2009-07-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.